Literature DB >> 23792768

Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.

Tristan M Nicholson1, Priyanka D Sehgal, Sally A Drew, Wei Huang, William A Ricke.   

Abstract

Androgens and estrogens, acting via their respective receptors, are important in benign prostatic hyperplasia (BPH). The goals of this study were to quantitatively characterize the tissue distribution and staining intensity of androgen receptor (AR) and estrogen receptor-alpha (ERα), and assess cells expressing both AR and ERα, in human BPH compared to normal prostate. A tissue microarray composed of normal prostate and BPH tissue was used and multiplexed immunohistochemistry was performed to detect AR and ERα. We used a multispectral imaging platform for automated scanning, tissue and cell segmentation and marker quantification. BPH specimens had an increased number of epithelial and stromal cells and increased percentage of epithelium. In both stroma and epithelium, the mean nuclear area was decreased in BPH relative to normal prostate. AR expression and staining intensity in epithelial and stromal cells was significantly increased in BPH compared to normal prostate. ERα expression was increased in BPH epithelium. However, stromal ERα expression and staining intensity was decreased in BPH compared to normal prostate. Double positive (AR and ERα) epithelial cells were more prevalent in BPH, and fewer double negative (AR and ERα) stromal and epithelial negative cells were observed in BPH. These data underscore the importance of tissue layer localization and expression of steroid hormone receptors in the prostate. Understanding the tissue-specific hormone action of androgens and estrogens will lead to a better understanding of mechanisms of pathogenesis in the prostate and may lead to better treatment for BPH.
Copyright © 2013 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-alpha reductase inhibitors; 5ARI; ACTA2; AR; Androgen receptor; BPH; Benign prostatic hyperplasia; DAB; ERα; Estrogen receptor-alpha; HT; IHC; LUTS; PSA; SERMs; TMA; TURP; androgen receptor; benign prostatic hyperplasia; d-amino benzene; estrogen receptor-alpha; hematoxylin; immunohistochemistry; lower urinary tract symptoms; prostate specific antigen; selective estrogen receptor modulators; smooth muscle alpha-actin; tissue microarray; transurethral resection of the prostate

Mesh:

Substances:

Year:  2013        PMID: 23792768      PMCID: PMC3729928          DOI: 10.1016/j.diff.2013.02.006

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  34 in total

1.  Steroid hormone receptors, matrix metalloproteinases, insulin-like growth factor, and dystroglycans interactions in prostatic diseases in the elderly men.

Authors:  A C Hetzl; W J Fávaro; A Billis; U Ferreira; V H A Cagnon
Journal:  Microsc Res Tech       Date:  2012-05-31       Impact factor: 2.769

2.  Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium.

Authors:  G Risbridger; H Wang; P Young; T Kurita; Y Z Wang; D Lubahn; J A Gustafsson; G Cunha; Y Z Wong
Journal:  Dev Biol       Date:  2001-01-15       Impact factor: 3.582

3.  Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group.

Authors:  C G Roehrborn; J D McConnell; M Lieber; S Kaplan; J Geller; G H Malek; R Castellanos; S Coffield; B Saltzman; M Resnick; T J Cook; J Waldstreicher
Journal:  Urology       Date:  1999-03       Impact factor: 2.649

4.  Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men.

Authors:  A Bélanger; B Candas; A Dupont; L Cusan; P Diamond; J L Gomez; F Labrie
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

5.  Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia.

Authors:  R Montironi; C Magi Galluzzi; M Scarpelli; I Giannulis; L Diamanti
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

6.  Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.

Authors:  Clement K M Ho; Jyoti Nanda; Karen E Chapman; Fouad K Habib
Journal:  J Endocrinol       Date:  2008-06       Impact factor: 4.286

7.  Prostatic inflammation and obstructive voiding in the adult Noble rat: impact of the testosterone to estradiol ratio in serum.

Authors:  Jenni Bernoulli; Emrah Yatkin; Yvonne Konkol; Eva-Maria Talvitie; Risto Santti; Tomi Streng
Journal:  Prostate       Date:  2008-09-01       Impact factor: 4.104

8.  A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays.

Authors:  Wei Huang; Kenneth Hennrick; Sally Drew
Journal:  Hum Pathol       Date:  2012-08-31       Impact factor: 3.466

9.  Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice.

Authors:  Tristan M Nicholson; Emily A Ricke; Paul C Marker; Joseph M Miano; Robert D Mayer; Barry G Timms; Frederick S vom Saal; Ronald W Wood; William A Ricke
Journal:  Endocrinology       Date:  2012-09-04       Impact factor: 4.736

10.  Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors.

Authors:  J Kellogg Parsons
Journal:  Curr Bladder Dysfunct Rep       Date:  2010-09-07
View more
  28 in total

Review 1.  Estrogens and Male Lower Urinary Tract Dysfunction.

Authors:  Jalissa L Wynder; Tristan M Nicholson; Donald B DeFranco; William A Ricke
Journal:  Curr Urol Rep       Date:  2015-09       Impact factor: 3.092

2.  Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging.

Authors:  Tyler M Bauman; Emily A Ricke; Sally A Drew; Wei Huang; William A Ricke
Journal:  J Vis Exp       Date:  2016-04-08       Impact factor: 1.355

3.  Targeting a fibrotic bottleneck may provide an opening in the treatment of LUTS.

Authors:  William A Ricke; Reginald C Bruskewitz; Teresa T Liu
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-13

4.  Effects of Estrogen Receptor β Stimulation in a Rat Model of Non-Bacterial Prostatic Inflammation.

Authors:  Shinsuke Mizoguchi; Kenichi Mori; Zhou Wang; Teresa Liu; Yasuhito Funahashi; Fuminori Sato; Donald B DeFranco; Naoki Yoshimura; Hiromitsu Mimata
Journal:  Prostate       Date:  2017-02-09       Impact factor: 4.104

Review 5.  Targeting phenotypic heterogeneity in benign prostatic hyperplasia.

Authors:  Douglas W Strand; Daniel N Costa; Franto Francis; William A Ricke; Claus G Roehrborn
Journal:  Differentiation       Date:  2017-08-04       Impact factor: 3.880

6.  Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues.

Authors:  Tyler M Bauman; Priyanka D Sehgal; Karen A Johnson; Thomas Pier; Reginald C Bruskewitz; William A Ricke; Wei Huang
Journal:  Prostate       Date:  2014-04-30       Impact factor: 4.104

7.  Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α-reductase 2.

Authors:  Zongwei Wang; Libing Hu; Keyan Salari; Seth K Bechis; Rongbin Ge; Shulin Wu; Cyrus Rassoulian; Jonathan Pham; Chin-Lee Wu; Shahin Tabatabaei; Douglas W Strand; Aria F Olumi
Journal:  J Pathol       Date:  2017-12       Impact factor: 7.996

8.  Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction.

Authors:  Erin M McAuley; Devkumar Mustafi; Brian W Simons; Rebecca Valek; Marta Zamora; Erica Markiewicz; Sophia Lamperis; Anthony Williams; Brian B Roman; Chad Vezina; Greg Karczmar; Aytekin Oto; Donald J Vander Griend
Journal:  Am J Pathol       Date:  2017-08-18       Impact factor: 4.307

9.  Tissue-specific quantification and localization of androgen and estrogen receptors in prostate cancer.

Authors:  Priyanka D Sehgal; Tyler M Bauman; Tristan M Nicholson; Jordan E Vellky; Emily A Ricke; Weiping Tang; Wei Xu; Wei Huang; William A Ricke
Journal:  Hum Pathol       Date:  2019-05-03       Impact factor: 3.466

10.  Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.

Authors:  Kouji Izumi; Lei Li; Chawnshang Chang
Journal:  Clin Investig (Lond)       Date:  2014-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.